CANF Competitors & Alternatives
Compare Can Fite Biopharma Ltd ADR with similar stocks in the same industry
Biotechnology
CANF
Main Stock$3.17
Tradestie Score
50
Market Cap
$9.67M
Revenue Growth
-0.4%
Analyst Upside
+152.4%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.81
|
$133.50M | - | 56 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.29
|
$114.01M | - | 49 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.27
|
$110.20M | - | 55 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.30
|
$71.69M | - | 52 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.42
|
$67.94M | - | 51 | Compare |
|
BLRX
BioLineRX Ltd
|
$2.66
|
$16.50M | - | 53 | Compare |
|
RDHL
Redhill Biopharma Ltd.
|
$0.65
|
$8.39M | - | 49 | Compare |
|
CETX
CEMTREX INC.
|
$2.66
|
$4.26M | 0.0 | 47 | Compare |
|
HEPA
HEPA
|
- | - | - | - | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
More CANF Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry